Endogenous cannabinoid system. Effect on neuronal plasticity and pain memory;Endogenes cannabinoidsystem. Einfluss auf neuronale plastizität und schmerzgedächtnis

Schmerz

Volumn 19, Issue 6, 2005, Pages 521-527

  Azad, S C ^a,b   Huge, V ^a,b   Schops P ^c   Hilf, C ^a   Beyer, A ^b   Dodt, H U ^a   Rammes, G ^a   Zieglgansberger W ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Krankenhaus Harlaching   (Germany)

Author keywords

Amygdala; Cannabinoids; CB1 receptor; Long term potentiation; Synaptic plasticity

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN SLICE; CONTROLLED STUDY; DRUG INHIBITION; ELECTROSTIMULATION; LONG TERM POTENTIATION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; RECEPTOR BLOCKING; RECEPTOR SENSITIVITY; SPECIES COMPARISON; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE;

CANNABINOIDS; ELECTRIC STIMULATION; ENDORPHINS; HUMANS; MEMORY; NEURONAL PLASTICITY; PAIN; RECEPTORS, CANNABINOID;

EID: 27944486784     PISSN: 0932433X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00482-004-0342-2     Document Type: Article

References (29)

1. Alger BE (2002) Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 68: 247-286
2. Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58: 315-348
3. Auclair N, Otani S, Soubrie P, Crepel F (2000) Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol 83: 3287-3293
4. 9-THC-induced central nervous system effects in the mouse. Eur J Neurosci 13: 561-568
5. Azad SC, Eder M, Marsicano G, Lutz B, Zieglgänsberger W, Rammes G (2003) Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. Learn Mem 10: 116-128
6. Breivogel CS, Childers SR (1998) The functional neuroanatomy of brain cannabinoid receptors. Neurobiol Dis 5: 417-431
7. Campbell FA, Tramer MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ (2001) Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 323: 13-16
8. Davis M, Rainnie D, Cassell M (1994) Neurotransmission in the rat amygdala related to fear und anxiety. Trends Neurosci 17: 208-214
9. Deadwyler SA, Hampson RE, Mu J, Whyte A, Childers S (1995) Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J Pharmacol Exp Ther 273: 734-743
10. Di Marzo V, Deutsch DG (1998) Biochemistry of the endogenous ligands of cannabinoid receptors. Neurobiol Dis 5: 386-404
11. Gerdeman GL, Ronesi J, Lovinger DM (2002) Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat Neurosci 5: 446-451
12. Hajos N, Ledent C, Freund TF (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106: 1-4
13. Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283: 401-404
14. Manning BH, Merin NM, Meng ID, Amaral DG (2001) Reduction in opioid- and cannabinoid-induced antinociception in rhesus monkeys after bilateral lesions of the amygdaloid complex. J Neurosci 21: 8238-8246
15. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgänsberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534
16. Martin WJ, Coffin PO, Attias E, Balinsky M, Tsou K, Walker JM (1999) Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Res 822: 237-242
17. Matsuda LA, Bonner TI, Lolait SJ (1993) Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327: 535-550
18. Mechoulam R, Fride E, Di Marzo V (1998) Endocannabinoids. Eur J Pharmacol 359: 1-18
19. Misner DL, Sullivan JM (1999) Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J Neurosci 19: 6795-6805
20. Neugebauer V, Li W (2002) Processing of nociceptive mechanical und thermal information in central amygdala neurons with knee-joint input. J Neurophysiol 87: 103-112
21. Noyes R jr, Brunk SF, Avery DA, Canter AC (1975) The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther 18: 84-89
22. Paulson PE, Casey KL, Morrow TJ (2002) Long-term changes in behavior and regional cerebral blood flow associated with painful peripheral mononeuropathy in the rat. Pain 95: 31-40
23. Pertwee RG (2001) Cannabinoid receptors and pain. Prog Neurobiol 63: 569-611
24. Rogan MT, Stäubli UV, LeDoux JE (1997) Fear conditioning induces associative long-term potentiation in the amygdala. Nature 390: 604-607
25. Villemure C, Bushnell MC (2002) Cognitive modulation of pain: how do attention and emotion influence pain processing? Pain 95: 195-199
26. Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296: 678-682
27. Zieglgänsberger W, Tölle TR (1993) The pharmacology of pain signalling. Curr Opin Neurobiol 3: 611-618
28. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96: 5780-5785
29. Zimmermann M (2001) Pathobiology of neuropathic pain. Eur J Pharmacol 429: 23-37